ScienceGeist

Elsevier argues that they make their citation data available through their subscription database, Scopus, and that “[…] Elsevier cannot make such a large corpus of data, which it has added significant value to, available for free."

If South Africa truly wants to encourage good research, it must stop paying academics by the paper.

Printer closures and paper shortages create scheduling headaches for academic authors and staff at university presses.

End of prestigious print publication after 103 years stirs debate over future of journal publishing in the digital age.

BMC Biology's 'portable peer review' policy aims to save editors and researchers time and effort, but academics question whether authors will want to share details of past rejections.

While 18,000 retractions may sound like a lot, that amount is clearly just a fraction of the total number of papers that are a problem, as surveys indicate.

Visionaries thought technology would change books. Instead, it's changed everything about publishing a book.

Funders and publishers have a lot to gain from sharing and aligning peer reviews.

Any scientist publishing a claim should quantify their confidence in it with a probability, argues Steven N. Goodman.

More than 1,400 researchers sign an online letter arguing that Plan S will not impinge on academic freedom, as some critics claim.

Plan S implementation guidance has not provided reassurance to anxious society publishers.

Getting the most out of your Google Scholar profile, creating some old-fashioned table of contents alerts, and simply setting aside time to periodically review key journal titles will ensure you rarely miss out on important research.

Scientific journals' creation of dedicated positions for rooting out misconduct before publication comes amid growing awareness of such issues.

A practical roadmap for scholarly publishers to implement data citation in accordance with the Joint Declaration of Data Citation Principles (JDDCP).

In its most recent publication, Education International examines the publishing giant Elsevier, whose success on the market is based on ethically questionable practices which endanger the transmission of knowledge and its condition as a public good.

Ideas in support of an upward trend in universities and academics setting up their own presses in an environment increasingly dominated by large commercial publishing houses.

The development of a brand-new version of Libero will be governed under a model that puts the community at the heart of the project.

Gerard Meijer closed the first open access (offsetting) deals with the major scientific publishers. As his fellow scientists now oppose the new 'Plan S' he looks on with surprise and disappointments.

Academic publisher Elsevier has repeatedly made the news for its battle with Sci-Hub, the "Pirate Bay" of science. However, while Elsevier is using copyrights to protect its business, academic-insiders accuse the publisher of "anti-competitive" actions.

The EUA Council adopted a statement expressing its concern about the lack of transparency and competition in the scholarly publishing business sector in Europe. 

Unclear and incomplete journal guidelines are placing an additional burden on many scientists who don't speak English as a first language.

A new journal will allow academics to publish controversial articles under a pseudonym.

The spate of high-profile cases of fraudulent publications has revealed a widening replication, or outright deception, crisis in the social sciences. To Marc Spooner, researchers “cooking up” findings and the deliberate faking of science is a result of extreme pressures to publish, brought about by an increasingly pervasive audit culture within the academy.

The site shows more and more studies are being pulled from the scientific record.

Two leading university presses are changing the way they sell their digital collections to libraries - cutting out the middlemen. Will others follow suit?

The eLife website now has a dedicated section for plain-language summaries of the latest research.

The papers from the lab of Dr. Piero Anversa, who studied cardiac stem cells, 'included falsified and/or fabricated data,' according to a statement from the two institutions.